In the lack of laboratory criteria, such as LAC, aCL, and B2GP1 Abs, clinical signs strongly suggestive of APS were initially described as SN‐APS by Hughes and Khamashta in 2003 [1, 2, 3]. This evidence concerns the gene ACLY and autoimmune polyendocrinopathy.